PROTAC EZH2 Degrader-1 |
Catalog No.GC65509 |
PROTAC EZH2 Degrader-1 (composé 150d), un puissant dégradeur PROTAC EZH2, exerce un effet inhibiteur sur l'activité de la méthyltransférase EZH2 avec une IC50 de 2,7 nM. EZH2 joue un rÔle important dans de nombreux processus de tumorigenèse et de développement.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2641601-67-2
Sample solution is provided at 25 µL, 10mM.
PROTAC EZH2 Degrader-1 (Compound 150d), a potent PROTAC EZH2 Degrader, exerts inhibitory effect on EZH2 methyltransferase activity with the IC50 of 2.7 nM. EZH2 plays an important role in many tumorigenesis and development processes[1].
[1]. Juan Xia, et al. Targeting Enhancer of Zeste Homolog 2 for the Treatment of Hematological Malignancies and Solid Tumors: Candidate Structure-Activity Relationships Insights and Evolution Prospects. J Med Chem. 2022 May 26;65(10):7016-7043.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *